Pharmaceutical Technology E-Alert:
Having trouble viewing this e-mail? Click here.
You are subscribed to %%list.name%% as %%emailaddr%%.
Click here to unsubscribe or edit your member profile.
  Pharmaceutical Technology Europe E-Alert
 
16 March 2012

IN THIS ISSUE
DTC ads
EMA electronic pilot
GSK apprenticeships
GE Healthcare and Xcellerex
GMP collaboration


FDA issues guidance for US TV ads
The FDA has released a draft guidance for direct-to-consumer television advertisements that will require drug companies to submit their ads for review at least 45 days prior to dissemination. More...
 
EMA announces electronic applications pilot programme
The European Medicines Agency (EMA) has launched a pilot for submitting centralised marketing authorisation applications electronically, which marks a step towards using electronic applications as standard. More...
 
GSK launches UK apprenticeship scheme
GlaxoSmithKline is launching a new programme that will create apprenticeships in several areas including manufacturing and R&D at the company's UK sites. More...
 
GE Healthcare to acquire Xcellerex
GE Healthcare has announced an agreement to acquire Xcellerex, a supplier of manufacturing technologies for the biopharmaceutical industry, for an undisclosed amount. More...
 
Regulators expand international GMP collaboration
Medicine regulatory agencies in the EU, US and Australia have been successfully collaborating for some time now in the area of GMP inspections of API manufacturers, but now the partners are seeking to further expand the international effort by looking to include additional partners. More...
 
Join our community on LinkedIn
Want to discuss any of this week's news stories or any other hot topics in the industry? Then why not join our group on LinkedIn? More...
Key Topics:

Latest blog posts
Expanding international GMP collaboration
Time is of the essence
IT and operational technology convergence: are you ready?
More blog posts

PTE Digital
Optimising adjuvant filtration
Parametric release and real-time release testing
Evaluating impurities
Full issue

Upcoming events
9th Annual Controlled Release (28–29 March | UK)
2012 PDA Annual Meeting (16–18 April | USA)
LogiPharma (24–26 April | Switzerland)
More events

Products/Service Profiles
Hospira One 2 One

Hospira One 2 One® contract development and fill-finish manufacturing of injectable products packaged in vials, PFS, cartridges, ampoules. Broad range of capabilities: Biologics; Potent drugs; Vaccines; Cytotoxics; Beta-lactams; Lyophilization.
Read more

 
New Mill

2-Day Webcast Auction Sale of Contract Pharmaceuticals Limited Niagara - April 18 & 19, Buffalo, NY, 500,000 Sq. Ft. Contract Processing & Packaging Facility.
Read more

 
Shimadzu

The Nexera MP UHPLC for LC/MS analysis
Shimadzu has introduced the Nexera MP UHPLC as a Front End system for LC/MS. The Nexera MP is perfect for LC/MS analysis conducted in pharmacokinetics and synthesis stages in drug detection processes.
Read more


Event Profile
PDA

Pharma Outsourcing & Procurement Summit 2012
The Pharma Outsourcing and Procurement Summit 2012 addresses the urgent need for pharma to identify and locate the best outsourcing partnerships and solutions to stay competitive in an uncertain climate whilst addressing heightened regulatory pressures and need to maintain high quality standards. Read more

Survey
What does your company place the most emphasis on when analyzing tablet powder properties?
Particle characteristics 19%
 
Bulk powder properties 5%
     
Blend uniformity 25%
     
We consider these properties equally 51%

This week we would like to know...

What has been the most significant development in biologic-based drug manufacturing over the past 10 years?

Click here to vote

Contact Us
Click here to contact editorial.

Click here to contact sales.

 
You are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile

To ensure delivery to your inbox, please add us to your address book. If you need help doing this, click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact
information available to third parties for marketing purposes, please contact us by emailing [email protected] or by mail
at Advanstar Communications Inc., Bridgegate Pavilion, 4A Chester Business Park, Wrexham Road, Chester, CH4 9QH, UK.